Free Trial

Insider Selling: Itron, Inc. (NASDAQ:ITRI) SVP Sells 339 Shares of Stock

Itron logo with Computer and Technology background

Itron, Inc. (NASDAQ:ITRI - Get Free Report) SVP Christopher E. Ware sold 339 shares of the company's stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $114.95, for a total value of $38,968.05. Following the completion of the sale, the senior vice president now owns 19,468 shares in the company, valued at $2,237,846.60. This trade represents a 1.71% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Itron Stock Up 2.1%

ITRI stock traded up $2.44 during trading on Friday, reaching $116.15. 649,684 shares of the stock were exchanged, compared to its average volume of 577,070. The firm's 50 day moving average is $106.85 and its 200 day moving average is $107.70. The firm has a market cap of $5.30 billion, a P/E ratio of 23.80, a price-to-earnings-growth ratio of 0.81 and a beta of 1.31. The company has a current ratio of 3.36, a quick ratio of 2.83 and a debt-to-equity ratio of 0.91. Itron, Inc. has a twelve month low of $90.11 and a twelve month high of $124.90.

Itron (NASDAQ:ITRI - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The scientific and technical instruments company reported $1.52 EPS for the quarter, beating the consensus estimate of $1.30 by $0.22. Itron had a return on equity of 19.03% and a net margin of 9.37%. The firm had revenue of $607.15 million during the quarter, compared to the consensus estimate of $608.86 million. During the same quarter in the previous year, the company posted $1.24 earnings per share. The company's quarterly revenue was up .6% on a year-over-year basis. As a group, research analysts forecast that Itron, Inc. will post 5.33 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on ITRI shares. Guggenheim reaffirmed a "buy" rating and issued a $133.00 price objective on shares of Itron in a research note on Thursday, April 17th. Wall Street Zen raised shares of Itron from a "hold" rating to a "buy" rating in a research report on Saturday, May 24th. Piper Sandler decreased their price target on Itron from $124.00 to $121.00 and set a "neutral" rating for the company in a report on Monday, May 5th. Canaccord Genuity Group boosted their price objective on Itron from $130.00 to $132.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Finally, Oppenheimer raised their target price on Itron from $124.00 to $131.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 26th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, Itron has a consensus rating of "Moderate Buy" and an average target price of $127.36.

Get Our Latest Stock Report on Itron

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Janney Montgomery Scott LLC lifted its stake in shares of Itron by 45.9% in the fourth quarter. Janney Montgomery Scott LLC now owns 16,674 shares of the scientific and technical instruments company's stock valued at $1,810,000 after buying an additional 5,249 shares in the last quarter. Mount Yale Investment Advisors LLC acquired a new stake in shares of Itron in the 4th quarter worth about $286,000. Moody Aldrich Partners LLC lifted its position in Itron by 7.3% in the 4th quarter. Moody Aldrich Partners LLC now owns 43,053 shares of the scientific and technical instruments company's stock valued at $4,675,000 after acquiring an additional 2,945 shares in the last quarter. Hager Investment Management Services LLC acquired a new position in Itron during the 4th quarter valued at about $67,000. Finally, Measured Wealth Private Client Group LLC boosted its stake in Itron by 9.7% during the 4th quarter. Measured Wealth Private Client Group LLC now owns 3,814 shares of the scientific and technical instruments company's stock valued at $414,000 after purchasing an additional 338 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company's stock.

About Itron

(Get Free Report)

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Featured Articles

Insider Buying and Selling by Quarter for Itron (NASDAQ:ITRI)

Should You Invest $1,000 in Itron Right Now?

Before you consider Itron, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.

While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines